{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:10:09Z","timestamp":1756368609381,"version":"3.44.0"},"reference-count":42,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,12,2]]},"abstract":"<jats:p>Ovarian cancer often presents at an advanced stage with widespread peritoneal and\/or extra-abdominal metastases. Complete cytoreduction is the mainstay of treatment for disease confined to peritoneum. But in patients with distant metastases, the role and rationale is less obvious. One of the the most common sites of extra-abdominal disease is the cardiophrenic lymph node (CPLN). In this paper, we described the management of a patient with International Federation of Gynecology and Obstetrics (FIGO) stage IVB epithelial ovarian carcinoma and widespread peritoneal and extra-abdominal metastases to the CPLN, who underwent complete cytoreduction including excision of enlarged CPLN, following neoadjuvant chemotherapy. We examined the literature to determine the prognostic value of enlarged CPLN and their relevance in managing patients with advanced ovarian cancer and found it as an adverse prognostic factor. Transdiaphragmatic excision of CPLN is feasible without major complications. But as its correlation with overall or progression-free survival is not yet evident, large-scale prospective studies are warranted.<\/jats:p>","DOI":"10.1136\/bcr-2017-221450","type":"journal-article","created":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T06:50:20Z","timestamp":1515826220000},"page":"bcr-2017-221450","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer"],"prefix":"10.1136","volume":"2018","author":[{"given":"Hasan Shahriar Md","family":"Nuruzzaman","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Hwei Ching","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravichandran","family":"Nadarajah","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Singapore General Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-8285","authenticated-orcid":false,"given":"Melissa","family":"Teo","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,13]]},"reference":[{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.1","unstructured":"World Cancer Research Fund International. Cancer facts and figures: data on specific cancers: Ovarian Cancer Statistics; [about 1 screen]. http:\/\/www.wcrf.org\/int\/ cancer-facts-figures\/data-specific-cancers\/ovarian-cancer-statistics (accessed 15 Dec 2016)."},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21235"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.3","doi-asserted-by":"crossref","unstructured":"Elattar A , Bryant A , Winter-Roach BA , et al . Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 2011:CD007565.doi:10.1002\/14651858.CD007565.pub2","DOI":"10.1002\/14651858.CD007565.pub2"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20920"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2015.12.007","article-title":"Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV","volume":"140","author":"Ataseven","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9260(97)80034-7"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.7","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ijgo.2015.06.007","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"131","author":"Berek","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2016.06.013","article-title":"FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited","volume":"142","author":"Ataseven","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","article-title":"Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer","volume":"141","author":"Prader","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ejso.2013.08.006","article-title":"Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers","volume":"39","author":"Elias","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2015.05.007","article-title":"The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer","volume":"138","author":"Raban","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.12","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-6-1"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.07.002"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.14","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181e833f5"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5001\/omj.2015.70","article-title":"Survival impact of secondary cytoreductive surgery for recurrent ovarian cancer in an Asian population","volume":"30","author":"Bhat","year":"2015","journal-title":"Oman Med J"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.16","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6328"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2517"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.040"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.01.029"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.20","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.4396"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.153"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(94)70090-7"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.051"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.24","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5145"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1248"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.26","first-page":"31446","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: implications for survival","volume":"8258","author":"Mert","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2013.07.093","article-title":"Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?","volume":"131","author":"Perri","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.09.001","article-title":"Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer","volume":"147","author":"Cowan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.29","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1245\/s10434-015-5015-0","article-title":"Preoperative prediction of cardiophrenic lymph node metastasis in advanced ovarian cancer using computed tomography","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gore.2016.05.006","article-title":"Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer","volume":"17","author":"LaFargue","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.04.023"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2012.12.023","article-title":"Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer","volume":"129","author":"Yoo","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/IGC.0000000000000983","article-title":"Feasibility of transabdominal cardiophrenic lymphnode dissection in advanced ovarian cancer: initial experience at a tertiary center","volume":"27","author":"Garbi","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.34","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ygyno.2015.06.002","article-title":"Transdiaphragmatic cardiophrenic lymph node resection for stage IV ovarian cancer","volume":"138","author":"LaFargue","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1999.17.3.767","article-title":"Natural history of stage IV epithelial ovarian cancer","volume":"17","author":"Bonnefoi","year":"1999","journal-title":"J Clin Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2015.05.003","article-title":"The impact of pleural disease on the management of advanced ovarian cancer","volume":"138","author":"Escayola","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2008.06.023","article-title":"Intra-thoracic cytoreduction of stage IV peritoneal malignancy: a case series","volume":"111","author":"Huang","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.04.027"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.05.018"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.09.047"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.41","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1245\/s10434-017-6051-8","article-title":"A review of thoracic and mediastinal cytoreductive techniques in advanced ovarian cancer: extending the boundaries","volume":"24","author":"Nasser","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2025082800465310000_2018.jan13_1.bcr-2017-221450.42","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6526"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-221450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:47:03Z","timestamp":1756367223000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-221450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,13]]},"references-count":42,"alternative-id":["10.1136\/bcr-2017-221450"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-221450","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,1,13]]}}}